Novel Therapeutic Approaches for Small Cell Lung Cancer: The Future has Arrived

le Pietanza, M. Catherine, Rudin, Charles M.
Foilsithe 2012

Small Cell Lung Cancer: Will Recent Progress Lead to Improved Outcomes?

le Pietanza, M. Catherine, Byers, Lauren Averett, Minna, John D., Rudin, Charles M.
Foilsithe in Clin Cancer Res (2015)

Q-TWiST Analysis to Assess Benefit–Risk of Pembrolizumab in Patients with PD-L1–Positive Advanced or Metastatic Non-small Cell Lung Cancer

le Huang, Min, Pietanza, M. Catherine, Samkari, Ayman, Pellissier, James, Burke, Thomas, Chandwani, Sheenu, Kong, Fansen, Pickard, A. Simon
Foilsithe in Pharmacoeconomics (2018)

Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial

le Basch, Ethan, Wood, William A, Schrag, Deborah, Sima, Camelia S, Shaw, Mary, Rogak, Lauren J, Kris, Mark G, Shouery, Marwan, Bennett, Antonia, Atkinson, Thomas, Pietanza, M Catherine
Foilsithe in Clin Trials (2015)

EGFR mutant lung adenocarcinomas treated first-line with the novel EGFR inhibitor, XL647, can subsequently retain moderate sensitivity to erlotinib

le Chmielecki, Juliann, Pietanza, M. Catherine, Aftab, Dana, Shen, Ronglai, Zhao, Zhiguo, Chen, Xi, Hutchinson, Katherine, Viale, Agnes, Kris, Mark G., Stout, Thomas, Miller, Vincent, Rizvi, Naiyer, Pao, William
Foilsithe 2012

Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

le D'Angelo, Sandra P., Pietanza, M. Catherine, Johnson, Melissa L., Riely, Gregory J., Miller, Vincent A., Sima, Camelia S., Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Foilsithe 2011

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma – rationale for comprehensive mutation profiling

le Chaft, Jamie E., Arcila, Maria E., Paik, Paul K., Lau, Christopher, Riely, Gregory J., Pietanza, M. Catherine, Zakowski, Maureen F., Rusch, Valerie, Sima, Camelia, Ladanyi, Marc, Kris, Mark G.
Foilsithe 2011

Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non–small cell lung cancer without tumor PD‐L1 expression: A pooled analysis of 3 randomized con...

le Borghaei, Hossein, Langer, Corey J., Paz‐Ares, Luis, Rodríguez‐Abreu, Delvys, Halmos, Balazs, Garassino, Marina C., Houghton, Baerin, Kurata, Takayasu, Cheng, Ying, Lin, Jianxin, Pietanza, M. Catherine, Piperdi, Bilal, Gadgeel, Shirish M.
Foilsithe in Cancer (2020)

BRIEF REPORT: SMALL CELL LUNG CANCERS IN PATIENTS WHO NEVER SMOKED CIGARETTES

le Varghese, Anna M., Zakowski, Maureen F., Yu, Helena A., Won, Helen H., Riely, Gregory J., Krug, Lee M., Kris, Mark G., Rekhtman, Natasha, Ladanyi, Marc, Wang, Lu, Berger, Michael F., Pietanza, M. Catherine
Foilsithe 2014

Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR mutant advanced lung cancers that have developed acquired resistance to EGFR tyr...

le Yu, Helena A., Sima, Camelia S., Huang, James, Solomon, Stephen B., Rimner, Andreas, Paik, Paul, Pietanza, M. Catherine, Azzoli, Christopher G., Rizvi, Naiyer A., Krug, Lee M., Miller, Vincent A., Kris, Mark G., Riely, Gregory J.
Foilsithe 2013

Patterns of failure in limited-stage small cell lung cancer: implications of TNM stage for prophylactic cranial irradiation

le Wu, Abraham J., Gillis, Andrea, Foster, Amanda, Woo, Kaitlin, Zhang, Zhigang, Gelblum, Daphna Y., Downey, Robert J., Rosenzweig, Kenneth E., Ong, Leonard, Perez, Carmen A., Pietanza, M. Catherine, Krug, Lee, Rudin, Charles M., Rimner, Andreas
Foilsithe in Radiother Oncol (2017)

Trial of a 5-Day Dosing Regimen of Temozolomide in Patients with Relapsed Small Cell Lung Cancers with Assessment of Methylguanine-DNA Methyltransferase

le Zauderer, Marjorie G., Drilon, Alex, Kadota, Kyuichi, Huberman, Kety, Sima, Camelia S., Bergagnini, Isabella, Sumner, Dyana K., Travis, William D., Heguy, Adriana, Ginsberg, Michelle S., Holodny, Andrei I., Riely, Gregory J., Kris, Mark G., Krug, Lee M., Pietanza, M. Catherine
Foilsithe in Lung Cancer (2014)

A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer

le Pietanza, M. Catherine, Litvak, Anya M., Varghese, Anna M., Krug, Lee M., Fleisher, Martin, Teitcher, Jerrold B., Holodny, Andrei I., Sima, Cami S., Woo, Kaitlin M., Ng, Kenneth K., Won, Helen H., Berger, Michael F., Kris, Mark G., Rudin, Charles M.
Foilsithe in Lung Cancer (2016)

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

le Taylor, Matthew, Antonia, Scott, Bendell, Johanna, Calvo, Emiliano, Jäger, Dirk, de Braud, Filippo, Ott, Patrick A, Pietanza, M Catherine, Horn, Leora, Le, Dung T, Morse, Michael A, López-Martin, José A, Ascierto, Paolo A, Christensen, Olaf, Simon, Jason S, Lin, Chen-Sheng, Eder, Joseph Paul
Foilsithe in J Immunother Cancer (2015)

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

le Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G., Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A., Riess, Jonathan W., Jensen, Erin, Zhao, Bin, Pietanza, M. Catherine, Brahmer, Julie R.
Foilsithe in J Clin Oncol (2021)

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

le Rudin, Charles M., Awad, Mark M., Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K., Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J., Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P., Luo, Yiwen, Ebiana, Victoria, Pietanza, M. Catherine, Kim, Hye Ryun
Foilsithe in J Clin Oncol (2020)

Harnessing Technology to Improve Clinical Trials: Study of Real-Time Informatics to Collect Data, Toxicities, Image Response Assessments, and Patient-Reported Outcomes in a Phase I...

le Pietanza, M. Catherine, Basch, Ethan M., Lash, Alex, Schwartz, Lawrence H., Ginsberg, Michelle S., Zhao, Binsheng, Shouery, Marwan, Shaw, Mary, Rogak, Lauren J., Wilson, Manda, Gabow, Aaron, Latif, Marcia, Lin, Kai-Hsiung, Wu, Qinfei, Kass, Samantha L., Miller, Claire P., Tyson, Leslie, Sumner, Dyana K., Berkowitz-Hergianto, Alison, Sima, Camelia S., Kris, Mark G.
Foilsithe in J Clin Oncol (2013)

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

le Rudin, Charles M, Pietanza, M Catherine, Bauer, Todd M, Ready, Neal, Morgensztern, Daniel, Glisson, Bonnie S, Byers, Lauren A, Johnson, Melissa L, Burris, Howard A, Robert, Francisco, Han, Tae H, Bheddah, Sheila, Theiss, Noah, Watson, Sky, Mathur, Deepan, Vennapusa, Bharathi, Zayed, Hany, Lally, Satwant, Strickland, Donald K, Govindan, Ramaswamy, Dylla, Scott J, Peng, Stanford L, Spigel, David R
Foilsithe in Lancet Oncol (2016)

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer

le Pietanza, M. Catherine, Waqar, Saiama N., Krug, Lee M., Dowlati, Afshin, Hann, Christine L., Chiappori, Alberto, Owonikoko, Taofeek K., Woo, Kaitlin M., Cardnell, Robert J., Fujimoto, Junya, Long, Lihong, Diao, Lixia, Wang, Jing, Bensman, Yevgeniva, Hurtado, Brenda, de Groot, Patricia, Sulman, Erik P., Wistuba, Ignacio I., Chen, Alice, Fleisher, Martin, Heymach, John V., Kris, Mark G., Rudin, Charles M., Byers, Lauren Averett
Foilsithe in J Clin Oncol (2018)

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

le Saunders, Laura R., Bankovich, Alexander J., Anderson, Wade C., Aujay, Monette A., Bheddah, Sheila, Black, KristenAnn, Desai, Radhika, Escarpe, Paul A., Hampl, Johannes, Laysang, Amy, Liu, David, Lopez-Molina, Javier, Milton, Milly, Park, Albert, Pysz, Marybeth A., Shao, Hui, Slingerland, Brian, Torgov, Michael, Williams, Samuel A., Foord, Orit, Howard, Philip, Jassem, Jacek, Badzio, Andrzej, Czapiewski, Piotr, Harpole, David H., Dowlati, Afshin, Massion, Pierre P., Travis, William D., Pietanza, M. Catherine, Poirier, J. T., Rudin, Charles M., Stull, Robert A., Dylla, Scott J.
Foilsithe in Sci Transl Med (2015)